מפה צור קשר אודות המכון הדמיה כללית הדמית שד דף הבית  
 
 
Review of Breast Thermography
עמוד 1/7

By: William C. Amalu, DC, DABCT, DIACT, FIACT

Note: The following is not a comprehensive review of the literature. Over 30 years of research compiling over 800 studies in the index-medicus exist. What follows is a pertinent sample review of the research concerning the clinical application of diagnostic infrared imaging (thermography) for use in breast cancer screening. All the citations are taken from the index-medicus peer-reviewed research literature or medical textbooks. The authors are either PhD's with their doctorate in a representative field, or physicians primarily in the specialties of oncology, radiology, gynecology, and internal medicine.

The following list is a summary of the informational text that follows:

In 1982, the FDA approved breast thermography as an adjunctive breast cancer screening procedure.

• Breast thermography has undergone extensive research since the late 1950's.

• Over 800 peer-reviewed studies on breast thermography exist in the index-medicus literature.

• In this database, well over 300,000 women have been included as study participants.

• The numbers of participants in many studies are very large -- 10K, 37K, 60K, 85K …

• Some of these studies have followed patients up to 12 years.

• Strict standardized interpretation protocols have been established for over 20 years.

• Breast thermography has an average sensitivity and specificity of 90%.

• An abnormal thermogram is 10 times more significant as a future risk indicator for breast cancer than a first order family history of the disease.

• A persistent abnormal thermogram caries with it a 22x higher risk of future breast cancer.

• An abnormal infrared image is the single most important marker of high risk for developing breast cancer.

• Breast thermography has the ability to detect the first signs that a cancer may be forming up to 10 years before any other procedure can detect it.

• Research has shown that breast thermography significantly augments the long-term survival rates of its recipients by as much as 61%.

• When used as part of a multimodal approach (clinical examination + mammography + thermography) 95% of early stage cancers will be detected.

Next
 

     
www.thermomed.co.il | רחוב בראון 6, הרצליה 4658088 | טל. 09-9568866 | פקס. 09-9566656 | E-mail. info@thermomed.co.il
© כל הזכויות שמורות למכון להדמיה תרמוגרפית

Designed By FreeMind - Orna Ohayon
| Built By Lilush-Design